---
title: "NKGen Biotech Amends $5 Million BDW Loan, Pledging Real Estate as First-Lien Collateral"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293074756.md"
description: "NKGen Biotech amended its $5 million loan agreement with BDW Investments, replacing the all-assets security pledge with a first-priority lien on specific real estate. The amendment clarifies collateral priorities, bars other senior liens, and aligns the Senior Loan definition with a separate convertible facility. This change aims to better structure the company's capital stack while releasing certain claims in favor of the lender."
datetime: "2026-07-17T21:03:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293074756.md)
  - [en](https://longbridge.com/en/news/293074756.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293074756.md)
generator: "portal-rs"
---

# NKGen Biotech Amends $5 Million BDW Loan, Pledging Real Estate as First-Lien Collateral

NKGen Biotech entered into a First Amendment to its Equity and Business Loan Agreement with BDW Investments, updating the $5 million multi-draw term loan. The amendment replaces the prior all-assets security approach with a first-priority perfected lien on specified real estate and bars other senior liens on that collateral, except customary ones. It also updates the definition of the company’s Senior Loan to reference the April 15, 2026 senior convertible facility with AlpineBrook and includes a release of claims in favor of the lender. The changes clarify collateral priorities and align the loan with NKGen’s capital structure.

**Agreement details:**

-   **Agreement type**: First Amendment to Equity and Business Loan Agreement for $5 million multi-draw term loan
-   **Counterparty**: BDW Investments
-   **Signed / Effective**: Jul 13 2026 / Jul 13 2026
-   **Reason**: Update collateral and align with senior convertible financing

Original SEC Filing: NKGen Biotech, Inc. \[ NKGN \] - 8-K - Jul. 17, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [NKGN.US](https://longbridge.com/en/quote/NKGN.US.md)
- [NKGNW.US](https://longbridge.com/en/quote/NKGNW.US.md)

## Related News & Research

- [NKGen Biotech amends convertible loan deal with AlpineBrook, adds USD 1.05 million note](https://longbridge.com/en/news/297830645.md)
- [Infracore discloses key terms of its binding offer for the real estate of Wetzikon Hospital](https://longbridge.com/en/news/297734172.md)
- [Growexa Launches Lender-Ready Business Plan Platform to Bridge Small Business Lending Gap](https://longbridge.com/en/news/297990726.md)
- [Edmond de Rothschild Real Estate SICAV plans CHF 82 million ERRES Commercial Income capital hike in October 2026](https://longbridge.com/en/news/297674809.md)
- [LIVE MARKETS-The pillars of US housing market weakness: Apollo](https://longbridge.com/en/news/297680394.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**